References
- Arranz B., Eriksson A., Meilerup E., Plenge P., Marcusson J. Effect of aging in human cortical pre- and postsynaptic serotonin binding sites. Brain Research 1993; 620: 163–166
- Baez M., Yu L., Cohen M. L. Pharmacological and molecular evidence that the contractile response of serotonin in rat stomach fundus is not mediated by activation of the 5-hydroxy-tryptamine receptor. Molecular Pharmacology 1990; 38: 31–37
- Baxter G., Kennett G., Blaney F., Blackburn T. 5-HT2 receptor subtypes: a family re-united. Trends in Pharmacological Sciences 1995; 16: 105–110
- Brogden R. N., Sorkin E. M. Ketanserin. A review of its pharmacodynamic and pharmacokinetic properties, and theurapeutic potential in hypertension and peripheral vascular disease. Drugs 1990; 40: 903–949
- Brunello N., Riva M., Rovescalli A. C., Galimberti R., Racagni G. Age-related changes in rat serotonergic and adrenergic systems and in receptor responsiveness to subchronic desipramine treatment. Pharmacology and Toxicology 1988; 63: 150–155
- Dugovic C., Wauquier A. 5-HT2 receptors could be primarily involved in the regulation of slow-wave sleep in the rat. European Journal of Pharmacology 1987; 137: 145–146
- Dugovic C., Wauquier A., Leysen J. E., Marrannes R., Janssen P. A. J. Functional role of 5-HT2 receptors in the regulation of sleep and wakefulness in the rat. Psychopharmacology 1989; 97: 436–442
- Gottesmann C. The transition from slow-wave sleep to paradoxical sleep: evolving facts and concepts of the neurophysiological processes underlying the intermediate stage of sleep. Neuroscience Biobehavioral Reviews 1996; 20: 367–387
- Gozlan H., Daval G., Verge D., Spampinato U., Fattaccini C. M., Gallissot M. C., Mestikawy S., Hamon M. Aging associated changes in serotonergic and dopaminergic pre- and postsynaptic neurochemical markers in the rat brain. Neurobiology of Aging 1990; 4: 437–449
- Hoyer D. Molecular pharmacology and biology of 5-HTK: receptors. Trends in Pharmacological Sciences 1988; 9: 89–94
- Humphrey P. P. A., Harting P., Hoyer D. A proposed new nomenclature for 5-HT receptors. Trends in Pharmacological Sciences 1993; 14: 233–236
- Idzikowski C. The effects of ritanserin and seganserin on human slow wave sleep. Slow Wave Sleep: Physiological, Pathophysiological and Functional Aspects, A. Wauquier. Raven Press, New York 1989; 197–215
- Idzikowski C., Mills F. J., Glennard R. 5-hydroxytryptamine-2 antagonist increases human slow wave sleep. Brain Research 1986; 378: 164–168
- Leysen J. E. 5-HT2-receptors: location, pharmacological, pathological and physiological role. Serotonin Receptor Subtypes: Pharmacological Significance and Clinical Implications, S. Langer, N. Brunello, G. Racagni, J. Mendlewicz. Karger, Basel 1992; Vol. 1: 31–43
- Leysen J. E., Gommeren W., Van Gompel P., Wynants J., Janssen P. F. M., Laduron P. M. Receptor-binding properties in vitro and in vivo of ritanserin, a very potent and long acting serotonin-S2 antagonist. Molecular Pharmacology 1985; 27: 600–611
- Marcusson J., Morgan D. G., Winblad D. G., Finch C. E. Serotonin-2 binding sites in human frontal cortex and hippocampus. Selective loss of S2-A sites with age. Brain Research 1984; 311: 51–56
- Paxinos G., Watson C. The rat brain in stereotaxic coordinates. Academic Press, Sydney 1982
- Peroutka S. J., Snyder S. H. Interaction of antidepressants with neurotransmitter receptor sites. Antidepressants: neurochemical, behavioural, and clinical perspectives, S. J. Enna, J. B. Malick, E. Richlson. Raven Press, New York 1981; 75–90
- Sharpley A. L., Solomon R. A., Fernando J. M., Da Roza Davies J. M., Cowen P. J. Dose-related effects of selective 5-HT2 receptor antagonists on slow wave sleep in humans. Psychopharmacology 1990; 101: 568–569
- Sharpley A. L., Elliot J. M., Attenburrow M.-J., Cowen P. J. Slow wave sleep in humans: role of 5-HT2A and 5-HT2C receptors. Neuropharmacology 1994; 33: 467–471